The STENTYS® paclitaxel‐eluting stent in the treatment of unprotected distal left main

E-ISSN： 1522-726x|86|3|E131-E139

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.86, Iss.3, 2015-09, pp. : E131-E139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus- versus Paclitaxel-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis

Cardiology, Vol. 104, Iss. 4, 2005-10 ,pp. : 181-185

Karger

Access to resources Recommend Favorite

Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting

By Makikallio Timo Niemela Matti Kervinen Kari Jokinen Vesa Laukkanen Jari Ylitalo Kari Tulppo Mikko Juvonen Jukka Huikuri Heikki

Annals of Medicine, Vol. 40, Iss. 6, 2008-01 ,pp. : 437-443

Informa Healthcare

Access to resources Recommend Favorite

Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study

Cardiology, Vol. 113, Iss. 4, 2009-02 ,pp. : 264-273

Karger

Access to resources Recommend Favorite

Comparison of the Effect of Preinterventional Arterial Remodeling on Intimal Hyperplasia after Implantation of a Sirolimus- or Paclitaxel-Eluting Stent

Cardiology, Vol. 116, Iss. 2, 2010-06 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Five‐year clinical follow‐up of a randomized comparison of a polymer‐free sirolimus‐eluting stent versus a polymer‐based paclitaxel‐eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 418-424

John Wiley & Sons Inc

Access to resources Recommend Favorite